Akèy › Anplwayè › Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc.: Salè H-1B ak pajon
Akebia Therapeutics, Inc. depoze 11 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 11. Medyèn salè yo ofri a: $141,012.
Èske Akebia Therapeutics, Inc. pajone visa H-1B?
Akebia Therapeutics, Inc. depoze 11 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 14, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Clinical Pharmacologist | 2 | $141,012 |
| Associate CMC Project Manager | 1 | $81,078 |
| Senior, Drug Safety & PV Scientist | 1 | $168,717 |
| Principal Scientist (Drug Product) | 1 | $185,166 |
| Regulatory Specialist, Regulatory Affairs | 1 | $96,588 |
| Senior Oracle Solution Architect | 1 | $178,890 |
| Enterprise Architect | 1 | $114,537 |
| Sr. Oracle Solutions Architect | 1 | $166,837 |
| Senior Scientist, Analytical Sciences, CMC | 1 | $153,763 |
| Senior Specialist, Regulatory Affairs | 1 | $118,431 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 3 | $96,588 |
| FY2024 | 5 | $166,837 |
| FY2025 | 2 | $141,012 |
| FY2026 | 1 | $118,431 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Regulatory Affairs Specialists2
- Medical Scientists, Except Epidemiologists2
- Logisticians1
- Natural Sciences Managers1
- Chemical Engineers1
- Computer Systems Analysts1
- Business Intelligence Analysts1
- Software Developers, Systems Software1
- Chemists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Specialist, Regulatory Affairs | $118,431 Nivo II | Seattle, WA | Apr 14, 2026 | Sep 1, 2026 | Certifye |
| Clinical Pharmacologist | $141,012 Nivo II | Raleigh, NC | Aug 14, 2025 | Aug 18, 2025 | Certifye |
| Clinical Pharmacologist | $141,012 Nivo II | Fayetteville, NC | May 2, 2025 | Oct 1, 2025 | Certifye |
| Senior Scientist, Analytical Sciences, CMC | $153,763 Nivo IV | Cambridge, MA | Feb 8, 2024 | Jul 12, 2024 | Certifye |
| Regulatory Specialist, Regulatory Affairs | $96,588 Nivo II | Seattle, WA | Aug 5, 2023 | Sep 1, 2023 | Certifye |
| Senior Oracle Solution Architect | $178,890 Nivo IV | Cambridge, MA | Jul 7, 2023 | Jul 17, 2023 | Certifye, apre retire |
| Principal Scientist (Drug Product) | $185,166 Nivo IV | Somerset, NJ | Jun 21, 2023 | Jul 1, 2023 | Certifye, apre retire |
| Senior, Drug Safety & PV Scientist | $168,717 Nivo II | Cambridge, MA | Nov 17, 2021 | Nov 17, 2021 | Certifye, apre retire |
| Sr. Oracle Solutions Architect | $166,837 Nivo III | Cambridge, MA | Nov 17, 2021 | Nov 17, 2021 | Certifye, apre retire |
| Enterprise Architect | $114,537 Nivo IV | Cambridge, MA | Sep 9, 2021 | Oct 1, 2021 | Certifye, apre retire |
| Associate CMC Project Manager | $81,078–$114,760 Nivo III | Cambridge, MA | May 19, 2020 | Oct 1, 2020 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).